Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Huangshan Novel Co.,Ltd (002014.SZ)

10.68
-0.17
(-1.57%)
At close: April 30 at 3:04:51 PM GMT+8
Loading Chart for 002014.SZ
  • Previous Close 10.85
  • Open 10.99
  • Bid 10.66 x --
  • Ask 10.68 x --
  • Day's Range 10.64 - 10.88
  • 52 Week Range 8.05 - 12.29
  • Volume 4,330,560
  • Avg. Volume 5,863,977
  • Market Cap (intraday) 6.541B
  • Beta (5Y Monthly) 0.43
  • PE Ratio (TTM) 13.87
  • EPS (TTM) 0.77
  • Earnings Date --
  • Forward Dividend & Yield 0.62 (5.81%)
  • Ex-Dividend Date Apr 23, 2025
  • 1y Target Est --

Huangshan Novel Co.,Ltd manufactures and sells packaging materials in China and internationally. The company's packaging materials include plastic color-printing, laminating flexible, vacuum metallized and multi-functional film, medical packaging, breathable and protective membrane, and injection molding materials. Its products are used in food, dairy, pet food, daily chemicals, pharmaceutical, agrochemicals, electronics, architectural, building materials, and other applications. The company also exports its products to Europe, America, Mexico, Japan, the Middle East, and rest of Asia. Huangshan Novel Co.,Ltd was founded in 1992 and is headquartered in Huangshan City, China.

www.novel.com.cn

2,366

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002014.SZ

View More

Performance Overview: 002014.SZ

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002014.SZ
2.63%
SSE Composite Index (000001.SS)
2.17%

1-Year Return

002014.SZ
11.92%
SSE Composite Index (000001.SS)
5.61%

3-Year Return

002014.SZ
103.85%
SSE Composite Index (000001.SS)
7.61%

5-Year Return

002014.SZ
86.44%
SSE Composite Index (000001.SS)
14.65%

Compare To: 002014.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002014.SZ

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    6.54B

  • Enterprise Value

    5.68B

  • Trailing P/E

    13.87

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.84

  • Price/Book (mrq)

    2.44

  • Enterprise Value/Revenue

    1.60

  • Enterprise Value/EBITDA

    10.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.29%

  • Return on Assets (ttm)

    7.73%

  • Return on Equity (ttm)

    19.01%

  • Revenue (ttm)

    3.54B

  • Net Income Avi to Common (ttm)

    470.25M

  • Diluted EPS (ttm)

    0.77

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.76B

  • Total Debt/Equity (mrq)

    33.00%

  • Levered Free Cash Flow (ttm)

    -26.67M

Research Analysis: 002014.SZ

View More

Company Insights: 002014.SZ

Research Reports: 002014.SZ

View More

People Also Watch